Who owns ACASTI PHARMA INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Acasti Pharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Acasti Pharma stock

Who bought or sold ACASTI PHARMA INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Nantahala Capital Management 1.2M $3.5M 0% Sep 2025
 View chart
AIGH Capital Management 907k $2.7M -20% Sep 2025
 View chart
Vanguard Group 409k $1.2M 0% Sep 2025
 View chart
ADAR1 Capital Management 351k $1.0M 98% Sep 2025
 View chart
Stonepine Capital Management 211k $628k -28% Sep 2025
 View chart
Renaissance Technologies 85k $252k 206% Sep 2025
 View chart
Citadel Advisors 27k $81k -21% Sep 2025
 View chart
Millington Financial Advisors 20k $60k 0% Sep 2025
 View chart
SeaCrest Wealth Management 14k $42k 100% Sep 2025
 View chart
National Bank Of Canada /fi/ 2.7k $8.0k 0% Sep 2025
 View chart
Morgan Stanley 1.8k $5.5k 100% Jun 2025
 View chart
Tower Research Capital 1.6k $4.8k 19% Sep 2025
 View chart
Royal Bank of Canada 571.00 $2.1k 5% Sep 2025
 View chart
Activest Wealth Management 104.00 $310.003200 0% Sep 2025
 View chart
SBI Securities 101.00 $301.000200 0% Sep 2025
 View chart
Steward Partners Investment Advisory 41.00 $121.999600 0% Sep 2025
 View chart
Nbc Securities 2.00 $5.000000 100% Sep 2025
 View chart
Federation des caisses Desjardins du Quebec 1.00 $3.000000 0% Sep 2025
 View chart

Who sold out of Acasti Pharma?

Fund or Company Name Date Sold Shares Held Valued At
Palumbo Wealth Management Jun 2025 49k $144k
Jones Financial Companies, L.L Jun 2025 29.00 $85.999500
Jpmorgan Chase & Co Mar 2025 15.00 $34.000500